Home Biosimilar Antibodies Others Others Romosozumab(anti-sclerostin) For research use only.
Not for use in humans.

Romosozumab(anti-sclerostin)

Romosozumab is a monoclonal antibody that binds to sclerostin (an inhibitor of the Wingless-related integration site (Wnt) signaling pathway). It is a new osteoanabolic drug, that simultaneously increases bone formation and decreases bone resorption.

Romosozumab(anti-sclerostin)

Purity & Quality Control

Batch: A205001 Purity: 98% Protein concentration: 4.1mg/ml Endotoxin Level: <1 EU/mg
98

Biological Activity

Description Romosozumab is a monoclonal antibody that binds to sclerostin (an inhibitor of the Wingless-related integration site (Wnt) signaling pathway). It is a new osteoanabolic drug, that simultaneously increases bone formation and decreases bone resorption.

Product Details

CAS No. 909395-70-6
Molecular Weight 150 kDa
Isotype human IGg2, κ
Application Romosozumab(anti-sclerostin)
Purification Protein G
Sterility 0.2 μM filtered
Formulation PBS Buffer, PH 7.4
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Romosozumab(anti-sclerostin) | Romosozumab(anti-sclerostin) supplier | purchase Romosozumab(anti-sclerostin) | Romosozumab(anti-sclerostin) cost | Romosozumab(anti-sclerostin) manufacturer | order Romosozumab(anti-sclerostin) | Romosozumab(anti-sclerostin) distributor